In the ongoing battle against opioid addiction, innovative medications and treatments continue to emerge, providing hope to millions affected by this chronic condition. One such breakthrough is Brixadi®, a new medication designed to help individuals manage opioid use disorder (OUD). But what exactly is Brixadi®, and how does it work? In this blog, we will explore the details of this medication, its benefits, how it compares to other treatments, and what patients should know before starting therapy.
Understanding Opioid Use Disorder (OUD)
Opioid use disorder is a medical condition characterized by an inability to control opioid use despite harmful consequences. This disorder often leads to physical dependence and addiction, significantly impacting an individual’s quality of life. The U.S. has been grappling with an opioid crisis for years, with millions of people suffering from OUD due to the misuse of prescription pain relievers, heroin, or synthetic opioids like fentanyl.
Treatment options for OUD typically include behavioral therapy, counseling, and medications. Medications play a crucial role in managing cravings and withdrawal symptoms, making it easier for individuals to stay in recovery. Brixadi® offers a new and effective solution by providing extended relief through its innovative injectable formulation.
What Is Brixadi®?
Brixadi® is an extended-release injectable formulation of buprenorphine, a medication used to treat opioid use disorder. Developed by Braeburn Pharmaceuticals, Brixadi® offers a new approach to managing OUD through its unique delivery system. Unlike traditional buprenorphine treatments, which are taken daily in tablet or film form, Brixadi® is administered as a once-weekly or once-monthly injection, depending on the patient’s needs.
Buprenorphine, the active ingredient in Brixadi®, is a partial opioid agonist, which means it activates the opioid receptors in the brain but to a much lesser extent than full agonists like heroin or prescription opioids. By doing so, buprenorphine helps reduce cravings and withdrawal symptoms without producing the intense “high” associated with opioid misuse. This property makes it a valuable tool in treating OUD, allowing patients to stabilize their condition and focus on recovery.
How Does Brixadi® Work?
Brixadi’s® extended-release formulation steadily releases buprenorphine over a week or a month, depending on the dosing schedule. This sustained delivery helps maintain consistent levels of the medication in the bloodstream, reducing the risk of fluctuations that could lead to cravings or withdrawal symptoms.
The weekly or monthly injections are administered subcutaneously, meaning they are injected just under the skin, usually in the buttocks, thigh, or upper arm. The injection forms a small depot of medication that slowly releases buprenorphine into the bloodstream over time. This approach offers several advantages over daily oral medications:
Reduced Risk of Diversion and Misuse
Since Brixadi® is administered by a healthcare provider, it is less likely to be lost, stolen, or misused.
Improved Adherence
With fewer doses required, patients are more likely to adhere to their treatment plan, reducing the risk of relapse.
Stable Medication Levels
The extended-release formulation provides a steady release of medication, minimizing peaks and troughs in blood levels that could trigger withdrawal or cravings.
Benefits of Brixadi® Over Other Buprenorphine Treatments
Brixadi® offers several benefits over other buprenorphine treatments:
Convenience
The once-weekly or once-monthly injection schedule is more convenient for many patients than daily dosing, especially beneficial for individuals who have difficulty maintaining a daily medication routine due to lifestyle, work, or personal preferences.
Minimized Risk of Non-Adherence
With Brixadi®, the need for daily dosing is eliminated, which reduces the risk of missed doses and improves overall adherence to treatment.
Lower Potential for Abuse
Because Brixadi® is an injectable medication administered by healthcare professionals, the potential for diversion or misuse is significantly reduced compared to oral buprenorphine products.
Consistent Therapeutic Levels
Brixadi’s® extended-release formulation ensures that the medication is released steadily over time, maintaining consistent therapeutic levels in the bloodstream and reducing the risk of withdrawal symptoms or breakthrough cravings.
How Brixadi® Compares to Other Medications for OUD
Several medications are currently available for opioid use disorder, including methadone, naltrexone, and other formulations of buprenorphine. Here’s how Brixadi® compares:
Methadone
A full opioid agonist, Methadone, is taken daily under supervision and can be highly effective for OUD. However, it requires frequent visits to a clinic, which can be inconvenient. Additionally, because methadone is a full agonist, it has a higher risk of overdose and side effects compared to partial agonists like buprenorphine.
Naltrexone
Naltrexone is an opioid antagonist that blocks opioid receptors and prevents any opioid from having an effect. It is available in a once-monthly injectable form (Vivitrol). However, patients must be fully detoxed from opioids before starting naltrexone, which can be a barrier for some individuals.
Sublingual Buprenorphine
Traditional forms of buprenorphine are taken daily under the tongue. While effective, daily dosing can be less convenient, and there is a higher risk of non-adherence, diversion, and misuse.
Brixadi’s® once-weekly or once-monthly administration offers a middle ground, providing the benefits of buprenorphine with added convenience and reduced risk of misuse.
Considerations Before Starting Brixadi®
While Brixadi® offers several advantages, patients must discuss with their healthcare providers whether this medication suits them. Here are some factors to consider:
Allergies or Sensitivities
Patients should inform their healthcare providers of allergies or sensitivities to buprenorphine or other ingredients in Brixadi®.
Existing Medical Conditions
Individuals with certain medical conditions, such as severe respiratory problems, liver disease, or gastrointestinal issues, should consult their healthcare provider to determine if Brixadi® is a safe option.
Pregnancy and Breastfeeding
Women who are pregnant or breastfeeding should discuss the potential risks and benefits of using Brixadi® with their healthcare providers.
Potential Side Effects
Like all medications, Brixadi® may cause side effects. Common side effects include injection site reactions, headache, constipation, nausea, and drowsiness. Patients should report any severe or persistent side effects to their healthcare provider.
The Future of Brixadi® in OUD Treatment
As the opioid crisis continues to affect communities worldwide, the development of innovative treatments like Brixadi® is crucial. Brixadi® represents a promising new option for individuals with opioid use disorder, offering convenience, safety, and efficacy. As more research is conducted and real-world experience with Brixadi® grows, it has the potential to become a cornerstone in the fight against opioid addiction.
Is Brixadi® Right for You?
Deciding on the right treatment for opioid use disorder is a personal and complex decision that should be made in consultation with a healthcare professional. Brixadi® offers a new and effective option for many individuals, particularly those who may benefit from a less frequent dosing schedule and a reduced risk of misuse. If you or a loved one is struggling with opioid use disorder, talk to your healthcare provider about whether Brixadi® could be a suitable part of your treatment plan.
By understanding all available options and choosing a treatment plan tailored to your unique needs, you can take a significant step towards recovery and a healthier future.
Visit The Infinity Center-Frankfurt blog to learn more about addiction treatment, counseling, and more.